You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

February 5, 2020

China Tightens Food Safety Standards with Sweeping New Regulations on Food Importation

Southeast Asian food exporters to China should be aware of new regulations announced in late November 2019 by China’s General Administration of Customs (GAC) for all food products. The first is still in draft form and seeks to expand the scope of the GAC’s role in policing all food products, while the second update—already implemented–makes the application process for an import license for animal and plant food products much more rigorous. These two updates deal primarily with the GAC; applicants for an import license must also comply with the regulations of the Chinese Food and Drug Administration.

Draft Update

The GAC issued its Revised Draft Management Rules for the Registration of Overseas Production Enterprises of Imported Food on November 26, 2019, and accepted public comment until December 25, 2019. The draft proposes to expand the scope of registration—from the current requirement of having only overseas manufacturers of meat products, aquatic products, and dairy products register with the GAC—to extend to overseas manufacturers of all food categories who export their products to China. For example, under the draft, manufacturers will need to register with the GAC in categories such as health foods, foods for special medical purposes, infant foods, wines, prepackaged foods like beverages, candy, chocolates, and so on. This means that overseas manufacturers who were previously able to export their food products to China without registering for approval from the GAC will have to register their food products if the draft rules are implemented.

The draft imposes a new risk-based system for registration. Imported foods with higher levels of food safety risks—for example, meat, aquatic, dairy, and edible bird’s nest products—will merit greater scrutiny. Registration for low-risk food categories will be more straightforward and have simpler requirements. The draft also imposes increased responsibility on the exporting country’s local regulatory authority with regard to the supervision and management of manufacturers before, during, and after registration. If the local authority is deficient in its duties, the GAC may reject the manufacturer’s registration. The draft also puts more responsibility on the Chinese importer, which is required to check that the overseas food manufacturer has been properly registered with a confirmed name, address, and registration code.

New Regulations in Effect

Also on November 29, 2019, the GAC released new regulations that add additional scrutiny for foreign applicants looking to secure an import license for plant and animal food products. Applicants now need to undergo an initial documentation review before an application is accepted. Once the application is accepted, the GAC will then form two expert panels to examine the safety, hygiene conditions, and quality control system at the point of manufacture, as well as compliance aspects such as formal business registration and management systems in the applicant’s country of origin. The regulations also require compliance with Chinese regulations and standards, as well as adherence to labor standards equivalent to those imposed on companies registered in China. Current license holders will be able to export and distribute their items until their current license expires. After expiration, they will be subject to the new application procedures.

These new requirements coincide with new certification regulations for organic products, in effect from January 1, 2020. Under these changes, applications for organic certification will only be granted for products found in the “Organic Product Certification Catalogue.” Companies that have received prior certification for products not included in the list can continue using the granted certificate until expiration. However, after expiration, organic products not listed in the new catalogue will no longer be deemed organic-certified.

These new regulations signal a push for the GAC to play a more active role in importing food products from overseas manufacturers. It is recommended that all food exporters to China review their current practices and make sure they are aligned with the GAC’s new regulations currently enforced and those that will be enforced in the near future.

RELATED INSIGHTS​ 

July 8, 2026
On July 7, 2026, the Trade Competition Commission of Thailand (TCCT) issued a press release announcing the establishment of two new subcommittees designed to intensify oversight of digital platforms and modern trade businesses. The formation of the digital platform subcommittee marks a significant escalation in competition enforcement following the TCCT’s Guidelines on Multi-Sided Platforms and E-Commerce Businesses, which took effect on March 25, 2026. Platform operators, sellers, and related service providers should expect heightened regulatory scrutiny and potential investigations into practices already flagged under the March guidelines. Two Dedicated Enforcement Bodies The first new body is the digital platform subcommittee—formally the Subcommittee on Supervision, Monitoring, and Prevention of Trade Conduct in Digital Platform Business. It is tasked with driving intensive oversight of digital platform businesses. It will coordinate with government agencies, the private sector, business operators, and other relevant stakeholders to supervise and prevent trade conduct that may affect competition, and to promote free and fair competition in the digital platform sector. The subcommittee will be composed of TCCT members and representatives from the Department of Internal Trade. The second body—the Subcommittee on Determining Guidelines and Action Plans Concerning Competition Conditions in Modern Wholesale and Retail Business—will study, analyze, and monitor market structure in modern wholesale and retail businesses, compile databases to analyze retail business concentration, assess impacts on small-scale operators, and propose supervisory measures for the retail sector. TCCT members will serve on the subcommittee alongside experts from government and private organizations, including the Office of Industrial Economics, the Office of Small and Medium Enterprises Promotion, the Thai SME Federation, and the Thai SME Council. Operational Impact for Industry Participants These subcommittees provide the TCCT with a focused mechanism to investigate various trade practices deemed unfair, and the TCCT has authority under the Trade Competition Act to issue cease-and-desist
July 1, 2026
Obtaining marketing authorization is a fundamental requirement for bringing pharmaceutical products to the Thai market. Companies must navigate the Thai Food and Drug Administration’s registration procedures while also complying with post-approval pharmacovigilance obligations, licensing requirements for manufacturing and importation, data protection rules, and other regulatory requirements. This guide provides an overview of Thailand’s regulatory framework for pharmaceutical marketing authorization, including available registration pathways, review timelines, application fees, postmarketing surveillance obligations, licensing requirements, exemptions, data exclusivity, freedom of information, and parallel import considerations. It is intended as a practical reference for pharmaceutical companies, regulatory affairs professionals, and others involved in bringing medicinal products to the Thai market. Download the guide below for a concise overview of the current requirements and procedures governing pharmaceutical marketing authorization in Thailand.
June 29, 2026
Thailand’s cabinet has approved the draft Act on Liability for Defective Goods, commonly called Thailand’s “Lemon Law.” The Draft Act is currently pending consideration by Parliament. The draft law aims to strengthen buyers’ position in pursuing cases against sellers. While the Civil and Commercial Code offers provisions governing liability for defective goods, it is difficult in practice for buyers to successfully make a claim against sellers, particularly where defects are latent and not discoverable at the time of sale or delivery. By introducing product-specific rules and clearer remedies, the new law is intended to modernize Thailand’s consumer protection framework and align it more closely with international standards, and to help relieve the buyer’s burden of proof against the seller in product liability cases. If enacted, the draft act will take effect 180 days after publication in the Government Gazette, giving businesses a transition period to assess their compliance obligations. This article provides an overview of the key provisions of the draft act and highlights some practical considerations for businesses operating in Thailand. Scope and Key Definitions The draft act applies to sellers—defined as persons who sell goods in the ordinary course of business—and protects buyers, a term defined broadly to include not just the original purchaser but also transferees and successors in title. This expands the class of people who can bring claims. The law does not apply to used goods, live animals, or goods exempted by future ministerial regulation. It also leaves intact any separate warranties, promises, advertisements, or other guarantees a seller has given; those remain enforceable alongside the new statutory rights. General Liability for Defective Goods Sellers are liable for defects that exist at the time of delivery, regardless of whether the seller knew about them. Liability arises where a defect reduces: The benefit intended under
June 24, 2026
Patent enablement requirements are provided under Article 102 of Vietnam’s Law on Intellectual Property (IP Law). In particular, a patent specification must “fully and clearly disclose the nature of the invention to such an extent that, based on the specification, a person having ordinary skill in the relevant art can implement the invention.” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent Examination Guidelines (Guidelines) of the Intellectual Property Office of Vietnam (IP Office) were amended in March 2026 to introduce Annexes III and IV for the pharmaceutical and biotechnology sectors, in which Annex III provides detailed guidelines on the assessment of specification requirements. These amendments were made under a project for strengthening capacity in industrial property examination between the Japan International Cooperation Agency (JICA) and the IP Office. Annex III provides detailed instructions on how examiners assess enablement in a pharmaceutical or biotechnology application, and offers examples of acceptable and unacceptable descriptions with regard to the enablement aspect. Enablement Requirements in Pharma and Biotech Patents Article 12.7 of Circular 10/2026/TT-BKHCN (Circular 10) adds to the requirements of Article 102 of the IP Law that the description must demonstrate the novelty, inventive step, and industrial applicability of the technical solution. For pharmaceutical composition subject matters, Article 12.9 of Circular 10 sets out that the description must present the results of clinical trials and/or the pharmacological effects of the claimed pharmaceutical composition, and must include at least the following information: Substance/mixture used. Testing method (system) employed. Information on the test results. Correlation between the pharmacological effects obtained from the tests and the application of the pharmaceutical product in the prevention, diagnosis, and treatment of diseases. The Guidelines note that pharmacological study results should be presented in a quantified manner, and pharmacological